Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.66 |
| ▸ | TLR2 | O60603 | 18/20 | 0.61 |
| ▸ | TLR1 | Q15399 | 18/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL870999 | 1.00 | SIGMAR1 (0.66) | SIGMAR1TLR2TLR1 | |
| SCHEMBL17748295 | 0.99 | SIGMAR1 (0.67) | SIGMAR1TLR2TLR1 | |
| SCHEMBL7950428 | 0.94 | SIGMAR1 (0.69) | SIGMAR1TLR2TLR1 | |
| SCHEMBL7950429 | 0.94 | SIGMAR1 (0.69) | SIGMAR1TLR2TLR1 | |
| SCHEMBL11099171 | 0.86 | SIGMAR1 (0.50) | SIGMAR1TLR2TLR1 | |
| SCHEMBL11099169 | 0.86 | SIGMAR1 (0.50) | SIGMAR1TLR2TLR1 | |
| SCHEMBL11103397 | 0.86 | SIGMAR1 (0.50) | SIGMAR1TLR2TLR1 | |
| SCHEMBL11103394 | 0.86 | SIGMAR1 (0.50) | SIGMAR1TLR2TLR1 | |
| SCHEMBL4867322 | 0.84 | SIGMAR1 (0.63) | SIGMAR1TLR2TLR1 | |
| SCHEMBL4872861 | 0.84 | SIGMAR1 (0.63) | SIGMAR1TLR2TLR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077959-A1 | Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate | NATIONAL SCIENCE FOUNDATION | 2012-03-29 | — | — | US | disclosed |
| US-20120077959-A1 | Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate | NATIONAL SCIENCE FOUNDATION | 2012-03-29 | — | — | US | disclosed |
| WO-2010094029-A2 | ASYMMETRIC CYCLOPROPANATION WITH SUCCINIMIDYL DIAZOACETATE | UNIVERSITY OF SOUTH FLORIDA (US) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077959-A1 | Asymmetric Cobalt-Catalyzed Cyclopropanation With Succinimidyl Diazoacetate | SI, STOM, SUCLA2 | SIGMAR1 4290/4885TLR2 1175/4885TLR1 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.